Skip to main content

Advertisement

Log in

Is assaying autoantibodies useful for diagnosing early rheumatoid arthritis?

  • Viewpoint
  • Published:

From Nature Clinical Practice Rheumatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. O'Dell JR (2002) Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum 46: 283–285

    Article  Google Scholar 

  2. Pincus T et al. (Eds; 2003) Early Arthritis. In Clin Exp Rheumatol 21 (suppl 31): S1–S211

    Google Scholar 

  3. Nijenhuis S et al. (2004) Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta 350: 17–34

    Article  CAS  Google Scholar 

  4. Vittecoq O et al. (2004) Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis. Clin Exp Immunol 135: 173–180

    Article  CAS  Google Scholar 

  5. Rantapää-Dahlqvist S et al. (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48: 2741–2749

    Article  Google Scholar 

  6. Nielen MMJ et al. (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis. Arthritis Rheum 50: 380–386

    Article  Google Scholar 

  7. Lee DM and Schur PH (2003) Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 62: 870–874

    Article  CAS  Google Scholar 

  8. Vossenaar ER et al. (2004) Absence of citrulline-specific autoantibodies in animal models of autoimmunity. Arthritis Rheum 50: 2370–2372

    Article  CAS  Google Scholar 

  9. Hill JA et al. (2003) Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171: 538–541

    Article  CAS  Google Scholar 

  10. Van Gaalen FA et al. (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50: 709–715

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Walther J van Venrooij.

Ethics declarations

Competing interests

WJ van Venrooij is a scientific advisor of Euro-Diagnostica b.v. (Arnhem) and Axis-Shield Ltd (Dundee).

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Venrooij, W., van de Putte, L. Is assaying autoantibodies useful for diagnosing early rheumatoid arthritis?. Nat Rev Rheumatol 1, 4–5 (2005). https://doi.org/10.1038/ncprheum0018

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0018

  • Springer Nature Limited

Navigation